TheEdgeResearch
Home / Stocks / BHC

Bausch Health Companies Inc. (BHC)

NYSE Healthcare Drug Manufacturers - Specialty & Generic
$6.17 ▼ -1.20%
Market Cap
$2.31B
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
0.38
52-Wk Range
4.33-8.69
CEO
Thomas J. Appio
Country
CA
Currency
USD

Bausch Health Companies Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Laval, QC, CA. The stock last traded at $6.17, down 1.20% on the session, giving a market capitalisation of $2.31B. On trailing twelve-month figures it carries a trailing P/E of -2.09, a net margin of -10.1%. Its beta of 0.38 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-2.09
Price / Sales
0.21
Price / Book
-1.31
EV / EBITDA
10.39
Gross margin
71.8%
Operating margin
25.4%
Net margin
-10.1%
Return on equity
Debt / equity
-11.73
Current ratio
1.44
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
New York Stock Exchange
Employees
20,300
IPO date
1994-03-29
Headquarters
Laval, QC, CA
About Bausch Health Companies Inc.

Bausch Health Companies Inc., together with its associated entities, is engaged in the development, manufacturing, and commercialization of a diverse portfolio of pharmaceutical products, medical devices, and over-the-counter remedies. Its primary therapeutic focus areas include ophthalmology, digestive health, and dermatology. The enterprise conducts its operations through five principal divisions: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment is dedicated to vision care, encompassing surgical instruments, consumer eye health products, and ophthalmic pharmaceuticals. Salix specializes in delivering gastroenterology-specific products exclusively within the United States. The International Rx division markets Solta products, a range of branded and generic pharmaceuticals, OTC items, medical devices, and Bausch + Lomb offerings across diverse geographies including Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. Ortho Dermatologics focuses on dermatological products in the U.S., in addition to distributing Solta's medical aesthetic devices globally. Finally, the Diversified Products segment supplies pharmaceutical solutions for neurology and other therapeutic categories, as well as generic medications and dental products, all within the U.S. The company was formerly known as Valeant Pharmaceuticals International, Inc., officially changing its name to Bausch Health Companies Inc. in July 2018. Its corporate headquarters are located in Laval, Canada.

Comparable companies

Bausch Health Companies Inc. is most often compared with the following Healthcare names:

ALVOANIPBEAMCONCPRXHAEHCMMLYSPRGOXRAY
More research on BHC
BHC technical analysis BHC TheEdge Score Compare against peers
Open full interactive analysis & DCF →